Lexology August 9, 2023
McDermott Will & Emery

Key players across the healthcare industry—including sponsors, contract research organizations (CROs), research sites, regulators and patient advocates—are well aware of the challenges associated with the prompt and effective identification and enrollment of study subjects. In this context, stakeholders should consider several important factors when developing and implementing study pre-screening and recruitment activities.

In Depth

Delays or failures in launching clinical trials can lead to millions of dollars in costs for sponsors and impede access to new or improved therapies and diagnostics for patients. As services and initiatives designed to address these challenges proliferate, it is important to consider key factors that can trigger legal, operational and business risks.

  1. Data Use and Sharing. It is important to consider what data...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, FDA, Govt Agencies, HIPAA, Trends
Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
GLP-1 Agents' Risks and Benefits Broader Than Previously Thought
The biggest challenges clinical trials will face in 2025
Leading Sales and Marketing Intelligence Providers and Technology Solutions for the Clinical Trials Industry
The Role of Clinical Trials in Modern Medicine

Share This Article